2876 Annexin I (ANXA I) is a calcium and phospholipid binding protein which serves as a substrate for the tyrosine kinase of the epidermal growth factor receptor (EGFR). ANXA1 has been implicated in apoptosis, cell differentiation and proliferation. Alterations in ANXA1 expression have been described in several tumor types, including breast cancer. However, the precise role and function of ANXA1 in breast cancer have yet to be established. Our goal was to study ANXA1 function in breast cancer cells using cellular in vitro models with defined levels of ANXA1 expression. To evaluate ANXA1 expression in breast cancer cells, Western blot analysis was performed. Low ANXA1 protein expression was detected in MDA-MB-453 whereas high levels of ANXA1 were found in MCF7 and MDA-MB-231. To study the effects of ANXA1 overexpression, retrovirus was used to infect MDA-MB-453 with an expression vector containing ANXA1 cDNA. Conversely, to evaluate the effects of silencing ANXA1 expression, MCF7 and MDA-MB-231, were stably infected with small inhibitory RNAs (siRNA) specific for ANXA1. The siRNAs resulted in varying levels of attenuation of endogenous ANXA1 protein expression in the three different cell lines as assessed by Western blot analysis. The generated cell lines were used to evaluate the effects of ANXA1 on anchorage independent growth in soft agar. Overexpression of ANXA1 resulted in a 50% reduction of colony growth of MDA-MB-453/cDNA cells. In contrast, suppression of ANXA1 in both MCF7 and MDA-MB-231 resulted in a two-fold increase in anchorage independent growth. We wanted to determine whether ANXA1 interacts with HER2/neu, an important? protein in breast cancer and a member of the EGFR family. ANXA1 protein levels were measured in BT-474 and MDA-MB-435 with silenced HER2/neu. In these cell lines, silenced HER2/neu have been previously shown to decrease proliferation and decrease tumor growth in nude mice (J Biol Chem. 6;279:4339,04). In both BT-474 and MDA-MB-435, silenced of HER2/neu was associated with higher ANXA1 protein expression. In conclusion, our studies indicate that ANXA1 has a potential role in the suppression of breast cancer cell growth. We have successfully developed in vitro models to further study the role and function of ANXA1 in breast cancer and to determine whether the interaction of ANXA1 and HER2/neu can be used as a therapeutic site.